METiS TechBio, an AI-driven nanodelivery biotech company, successfully debuted on the Hong Kong Stock Exchange, raising over HKD 2.1 billion in the largest healthcare IPO in Hong Kong for 2026. It is the world's first publicly listed AI-powered drug delivery and large-molecule biopharmaceutical company. The IPO attracted record-breaking subscription interest, including major global investors like BlackRock. METiS aims to revolutionize biomedicine with its proprietary AI nanodelivery platform, NanoForge, advancing drug development and targeted therapies across multiple diseases. The company plans to use IPO proceeds to boost R&D, clinical trials, and expand into animal health and anti-aging sectors, marking a significant step in AI-driven pharmaceutical innovation.
Fitness Champs Holdings Limited (FCHL), penyedia pendidikan olahraga air terkemuka di Singapura, akan mengadakan Rapat Umum Pemegang Saham Luar Biasa (RUPSLB) pada 29 Juni 2026, pukul 10 pagi waktu Singapura. Pemegang saham Kelas A dan Kelas B yang t...
Verizon's stock has demonstrated resilience recently compared to other telecom carriers, maintaining its status as a solid defensive investment. Despite poor performance in the last bear market, Verizon offers a strong 6% dividend yield that appears ...
Canary Capital launched the first US spot ETF for Hedera's native token HBAR, trading under ticker HBR on Nasdaq. The ETF holds actual HBAR tokens, not derivatives, with custody by BitGo and Coinbase, and charges a 0.95% fee. This fund provides tradi...
Audiera (BEAT) led crypto gainers with a 53.10% jump to $7.32, driven by increased user adoption and new partnerships in its blockchain-based music streaming platform. Other notable gainers include Provenance Blockchain, Monero, and World Liberty Fin...
AMD posted strong Q1 results with 37.8% revenue growth and a record $2.57 billion in free cash flow, reinforcing positive investor sentiment. Despite high valuation metrics, the company is expected to benefit from new AI infrastructure products shipp...
